News

Filter

Current filters:

None

8626 to 8635 of 95986 results

Eli Lilly 3rd-qtr 2011 sales grow 9% but costs hit profits

21-10-2011

US drug major Eli Lilly (NYSE: LLY) posted financial results for the third quarter of 2011 showing that,…

Eli LillyFinancialPharmaceutical

Syntaxin and Ipsen in up to $99 million collaboration on novel botulinum-toxin therapeutics

21-10-2011

French drugmaker Ipsen (Euronext: IPN) has entered into a global strategic collaboration with privately-held…

BiotechnologyIpsenLicensingPharmaceuticalResearchSyntaxin

Executive appointments at Bristol-Myers Squibb and Amgen

21-10-2011

US drug major Bristol-Myers Squibb (NYSE: BMY) has announced a series of related changes within its senior…

AmgenBiotechnologyBristol-Myers SquibbManagementPharmaceutical

Benefits of Boehringer’s Pradaxa come at high cost, study finds

20-10-2011

Treating patients with the new blood thinning medication dabigatran (German independent drug major Boehringer…

Boehringer IngelheimCardio-vascularNorth AmericaPharmaceuticalPradaxaPricing

Prasco selected as Eli Lilly authorized generics partner for Zyprexa

20-10-2011

Privately-held US drugmaker Prasco Laboratories says it has signed a marketing and distribution agreement…

Eli LillyGenericsMarkets & MarketingNeurologicalNorth AmericaPrasco LaboratoriesZyprexa

Over 230K US pharma jobs will be lost under proposed mandatory Part D drug rebates, says think tank

20-10-2011

US President Barack Obama and some members of Congress have proposed requiring that prescription drug…

HealthcareNorth AmericaPharmaceuticalPoliticsPricingResearch

Sun Pharma offers to acquire remainder of Taro shares

20-10-2011

Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

8626 to 8635 of 95986 results

Back to top